Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
9.22
-0.28 (-2.95%)
At close: Jan 9, 2026, 4:00 PM EST
9.06
-0.16 (-1.76%)
After-hours: Jan 9, 2026, 5:06 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2010 - 2019
Novel Therapeutics
29.62M
Log In
Log In
Log In
Log In
Upgrade
Novel Therapeutics Growth
-79.95%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2010 - 2019
United States
26.11M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
101.48%
Log In
Log In
Log In
Log In
Upgrade
Europe
6.27M
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
-34.34%
Log In
Log In
Log In
Log In
Upgrade
China
91.00K
Log In
Log In
Log In
Log In
Upgrade
China Growth
-99.92%
Log In
Log In
Log In
Log In
Upgrade
Japan
-2.85M
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
-117.99%
Log In
Log In
Log In
Log In
Upgrade